Allopurinol hypersensitivity syndrome

Allopurinol hypersensitivity syndrome includes Stevens–Johnson syndrome, toxic epidermal necrolysis and drug reaction with eosinophilia and systemic symptoms. It affects about 1 in 1000 patients prescribed allopurinol, and reported mortality is between 20% and 25%.[1][1] Patients typically present